NorthCrest Asset Manangement’s Madrigal Pharmaceuticals MDGL Stock Holding History

NorthCrest Asset Manangement’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$423K	Buy	+888	New	+$469K	0.01%	706

Other funds holding MDGL

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $136M AUM 34.83% 1-Year Est. Return

NorthCrest Asset Manangement's MDGL Position: Q3 2026 in Review

NorthCrest Asset Manangement opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 888 shares worth $423K. The stake represents 0.01% of the portfolio and ranks #706 among its holdings.

28 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

NorthCrest Asset Manangement held 888 shares of Madrigal Pharmaceuticals worth $423K as of Q3 2026.
Madrigal Pharmaceuticals was a new NorthCrest Asset Manangement position in Q3 2026.
Madrigal Pharmaceuticals made up 0.01% of NorthCrest Asset Manangement's portfolio in Q3 2026, its #706 holding.
28 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q3 2026, filed 13 Oct 2026.